Cogent Healthcare Selected by Shands Jacksonville Medical Center
* Reuters is not responsible for the content in this press release.
BRENTWOOD, Tenn.--(Business Wire)-- Cogent Healthcare, a leader in hospital medicine, today announced a new agreement with Shands Jacksonville Medical Center of Jacksonville, Florida. Through the arrangement, Cogent will be the exclusive provider of comprehensive hospitalist services to Shands Jacksonville, one of eight hospitals in the Shands Healthcare network. "It is an honor to be partnering with Shands Jacksonville and the University of Florida College of Medicine," said Jim Panoff, Chief Development Officer of Cogent Healthcare. "Through our System of Care, Cogent will deliver very specific results that directly support Shands Jacksonville`s `Pillars of Excellence` for Quality, Service, People, Growth and Finance." This announcement comes on the heels of another recently formed relationship with an academic medical center, Erlanger Health System of Chattanooga, Tenn. Shands Jacksonville is a respected academic medical center serving 19 counties in northeast Florida, as well as several counties in southeast Georgia. Backed by a team of more than 400 University of Florida faculty physicians, Shands Jacksonville offers nearly 100 specialty services and is on the leading edge of the latest treatments and technologies. "Shands Jacksonville is committed to educational growth paired with providing outstanding service and exemplary quality of care to our patients," said Jim Burkhart, president and administrator of Shands Jacksonville. "By joining forces with a proven hospitalist program provider such as Cogent, we reaffirm our commitment to our patients, our medical staff and the surrounding Jacksonville community." "University of Florida faculty physicians are looking forward to the working relationship they will form with Cogent doctors to provide our patients the best possible outcomes," said Robert Nuss, MD, Dean of the regional campus, UF College of Medicine. "Cogent is well known for providing exceptional patient care as well as a commitment to quality, safety and efficiency. We`re confident the partnership will be mutually beneficial." Founded in 1997, Cogent is a pioneer and leader in the field of hospital medicine, the fastest growing medical specialty in the history of medicine. The company offers hospitals a comprehensive System of Care that supports hospitalists in the delivery of inpatient care and includes structure, a coordinated care team, data driven processes, rigorous ongoing training and experienced leadership. For more information about Cogent`s solutions and philosophy, visit www.cogenthealthcare.com. About Cogent Healthcare Founded in 1997, Cogent is a pioneer and leader in the field of hospital medicine. The company partners with hospitals to build and manage highly performing hospitalist programs. In order to relentlessly improve the care and efficiency of hospitalized patients, the Cogent model offers a comprehensive System of Care that supports hospitalists with structure, a coordinated care team, data driven processes, rigorous ongoing training and experienced leadership. Cogent physicians lead the profession by setting best practices for hospital medicine and providing a national mentoring program. For more information, visit www.cogenthealthcare.com. About Shands Jacksonville Shands Jacksonville is one of eight hospitals in the Shands HealthCare system, serving northeast Florida as well as several counties in southern Georgia. With 696 licensed beds, Shands Jacksonville is the largest acute-care hospital in the city. Shands Jacksonville is affiliated with the University of Florida College of Medicine - one of the leading research-oriented medical schools in the nation. Staffed by University of Florida faculty physicians, patients directly benefit from the scientific advancements available only at an academic medical center. Cogent Healthcare Carlie Crenshaw, 615-254-0575 or Shands Jacksonville Kelly Brockmeier, 904-244-3268 Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters